Home > Healthcare > Drug Device Combination > Hemostasis Products Market

Hemostasis Products Market Share

Report ID: GMI5287
Published Date: Aug 2023
Report Format: PDF

Download Free Sample

Hemostasis Products Market Share

The competitive landscape of the hemostasis products market includes prominent firms, such as

Johnson & Johnson
Pfizer
Baxter International
Medtronic
B. Braun Melsungen AG
Becton
Dickinson and Company (BD)
Tricol Biomedical
Hemostasis LLC
CuraMedical BV
Teleflex Incorporated

Authors: Mariam Faizullabhoy , Pratiksha Kamthe

Frequently Asked Questions (FAQ) :

Hemostasis products industry size was worth USD 1.6 billion in 2022 and is poised to record 5.8% CAGR from 2023-2032, driven by the escalating global prevalence of cardiac disorders.

Topical market accounted for USD 1.2 billion in 2022 and is estimated to record high demand through 2032 attributed to the advantages, such as ease of application, quick action, and reduced risk of complications.

North America market is expected to expand at 5.9% CAGR from 2023-2032 attributed to the presence of large geriatric population coupled with lifestyle-related factors such as obesity and sedentary habits

Some of the prominent hemostasis product companies are Johnson & Johnson, Pfizer, Baxter International, Medtronic, B. Braun Melsungen AG, Becton, Dickinson, and Company (BD), Tricol Biomedical, Hemostasis LLC, CuraMedical BV, and Teleflex Incorporated.